These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs. Hoot S; McGuire AT; Cohen KW; Strong RK; Hangartner L; Klein F; Diskin R; Scheid JF; Sather DN; Burton DR; Stamatatos L PLoS Pathog; 2013 Jan; 9(1):e1003106. PubMed ID: 23300456 [TBL] [Abstract][Full Text] [Related]
28. Reconstitution and characterization of antibody repertoires of HIV-1-infected "elite neutralizers". Sun Z; Li J; Hu X; Shao Y; Zhang MY Antiviral Res; 2015 Jun; 118():1-9. PubMed ID: 25770672 [TBL] [Abstract][Full Text] [Related]
29. Neutralization of tier-2 viruses and epitope profiling of plasma antibodies from human immunodeficiency virus type 1 infected donors from India. Andrabi R; Bala M; Kumar R; Wig N; Hazarika A; Luthra K PLoS One; 2012; 7(8):e43704. PubMed ID: 22952740 [TBL] [Abstract][Full Text] [Related]
30. Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies. Ahmed Y; Tian M; Gao Y AIDS Res Ther; 2017 Sep; 14(1):50. PubMed ID: 28893278 [TBL] [Abstract][Full Text] [Related]
31. HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies. Richardson SI; Chung AW; Natarajan H; Mabvakure B; Mkhize NN; Garrett N; Abdool Karim S; Moore PL; Ackerman ME; Alter G; Morris L PLoS Pathog; 2018 Apr; 14(4):e1006987. PubMed ID: 29630668 [TBL] [Abstract][Full Text] [Related]
32. Mapping of Neutralizing Antibody Epitopes on the Envelope of Viruses Obtained from Plasma Samples Exhibiting Broad Cross-Clade Neutralization Potential Against HIV-1. Cheedarla N; Sundaramurthi JC; Hemalatha B; Anangi B; Nesakumar M; Ashokkumar M; Vidya Vijayan KK; Tripathy SP; Swaminathan S; Vaniambadi SK; Ramanathan DV; Hanna LE AIDS Res Hum Retroviruses; 2019 Feb; 35(2):169-184. PubMed ID: 30328700 [TBL] [Abstract][Full Text] [Related]
33. Report of the Cent Gardes HIV Vaccine Conference: The B-cell Response to HIV. Part 1: Broadly Neutralizing Antibodies Fondation Mérieux Conference Center, Veyrier du Lac, France, 5-7 November 2012. Girard MP; Picot V; Longuet C; Nabel GJ Vaccine; 2013 Jun; 31(29):2979-83. PubMed ID: 23499518 [TBL] [Abstract][Full Text] [Related]
34. Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort. Landais E; Huang X; Havenar-Daughton C; Murrell B; Price MA; Wickramasinghe L; Ramos A; Bian CB; Simek M; Allen S; Karita E; Kilembe W; Lakhi S; Inambao M; Kamali A; Sanders EJ; Anzala O; Edward V; Bekker LG; Tang J; Gilmour J; Kosakovsky-Pond SL; Phung P; Wrin T; Crotty S; Godzik A; Poignard P PLoS Pathog; 2016 Jan; 12(1):e1005369. PubMed ID: 26766578 [TBL] [Abstract][Full Text] [Related]